A Phase 1 Study of PRT7732, an Oral SMARCA2 Degrader, in Patients with Advanced or Metastatic Solid Tumors with a SMARCA4 Mutation

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-512380-32-00

Acronym

PRT7732-01

Enrollment

Registered

2025-01-21

Start date

2025-03-03

Completion date

2025-11-26

Last updated

2025-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced or Metastatic Solid Tumors with a SMARCA4 Mutation, esophageal, gastric, Non-small cell lung cancer (NSCLC), or gastroesophageal junction adenocarcinoma, or gastroesophageal junction squamous cell carcinoma

Interventions

None listed

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Countries

Germany, Spain

Outcome results